Categories AlphaGraphs, Earnings, Health Care
Infographic: A snapshot of Moderna’s (MRNA) Q1 2024 earnings results
Moderna, Inc. (NASDAQ: MRNA) reported a net loss for the first quarter of 2024 when the biotechnology company’s revenues declined sharply. Q1 loss was $1.18 billion or $3.07, compared to a profit of $79 million or $0.19 per share in the prior-year period.
The bottom line was negatively impacted by a 91% fall in revenues to $167 million, reflecting a marked decline in product revenues. The management reaffirmed the full-year expected revenue of around $4 billion from its respiratory franchise, and now expects about $0.3 billion in net sales in the first half of the year, reflecting the seasonality of the respiratory business.
“With 10 late-stage programs, and additional new programs advancing toward pivotal studies, we continue to expect numerous product milestones this year across our vaccines and therapeutics portfolio. This is the start of a banner year for our vaccine platform as we continue to advance mRNA medicines for patients. This is just the beginning,” said Moderna’s CEO Stéphane Bancel.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Infographic: How Deere & Company (DE) performed in Q2 2024
Deere & Company (NYSE: DE) reported second quarter 2024 earnings results today. Total net sales and revenues decreased 12% year-over-year to $15.2 billion. Net income was $2.37 billion, or $8.53
WMT Earnings: Key quarterly highlights from Walmart’s Q1 2025 financial results
Walmart Inc. (NYSE: WMT) reported its first quarter 2025 earnings results today. Consolidated revenue increased 6% year-over-year to $161.5 billion. Revenue growth on a constant currency basis was 5.8%. Consolidated
Home Depot (HD): A look at how the home improvement retailer fared in Q1 2024
Shares of Home Depot (NYSE: HD) rose over 2% on Wednesday. The stock has gained 19% over the past 12 months. The company delivered mixed results for the first quarter